News Conference News SCAI 2021 Cardiogenic Shock: Protocols, Clear Definitions Advance the Field Caitlin E. Cox April 30, 2021
News Daily News Short-term Mechanical Circulatory Support: Take the Long View Caitlin E. Cox March 01, 2021
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Daily News ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights Caitlin E. Cox August 18, 2020
News Daily News Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest Shelley Wood August 05, 2020
News Features Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope Caitlin E. Cox June 02, 2020
News Daily News Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year Caitlin E. Cox May 08, 2020
News Daily News Multivessel PCI May Be Safe in Select Shock Patients With Impella Support Todd Neale April 29, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2020 Shelley Wood March 02, 2020
News Daily News Impella Redux: JAMA Publication Post-AHA Renews Push for More Data Caitlin E. Cox February 14, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2019 Shelley Wood November 29, 2019
News Conference News AHA 2019 More Adverse Events, Higher Costs With Impella: New Observational Studies Caitlin E. Cox November 17, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Daily News For Percutaneous LVADs, Vascular Complications Decreasing but Still Common Caitlin E. Cox November 06, 2019
News Conference News TCT 2019 NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival Caitlin E. Cox October 10, 2019
News Conference News TCT 2019 Strokes Increasing in STEMI Patients With Cardiogenic Shock Todd Neale September 25, 2019
News Daily News Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany Caitlin E. Cox May 14, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial May 02, 2019
News Daily News There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends Todd Neale April 10, 2019